You are here

UCF Digital Collections ยป Honors Collection

THE PRESENCE OF PAIN RELATED CYTOKINES AND CHEMOKINES IN SCHWANNOMAS AND THEIR POTENTIAL ASSOCIATION WITH CHRONIC PAIN IN SCHWANNOMATOSIS

Download pdf | Full Screen View

Date Issued:
2019
Abstract/Description:
Schwannomatosis (SWN) is a genetic disorder that predisposes affected individuals to develop multiple Schwannomas anywhere in the peripheral nervous system. This can be due to a mutation in the LZTR1 or SMARCB1 genes on chromosome 22. SWN has the defining clinical symptom of chronic pain and a lack of vestibular schwannomas, which sets it apart from other, related disorders such as Neurofibromatosis Type II (NF2). Currently, it is unknown what causes the chronic pain of SWN patients but it is hypothesized that cytokines may have promote the neuropathic pain experienced by patients. This study investigates the presence of the chemokine CCL2 and the cytokine IL6 in human SWN schwannomas and non-SWN schwannomas to determine if there is a difference in the presence of these cytokines between the two tumor types. It was demonstrated that all of the SWN schwannomas expressed both CCL2 and IL6 whereas the non-SWN schwannomas expressed only one or the other protein if either. These results indicate that the presence of these cytokines within the SWN schwannomas is different from non-SWN schwannomas and could be a potential contributing factor in the occurrence of neuropathic pain experienced by SWN which is part of the differential diagnosis for NF2 and SWN.
Title: THE PRESENCE OF PAIN RELATED CYTOKINES AND CHEMOKINES IN SCHWANNOMAS AND THEIR POTENTIAL ASSOCIATION WITH CHRONIC PAIN IN SCHWANNOMATOSIS.
18 views
9 downloads
Name(s): Nagamoto, Jackson D, Author
Fernandez-Valle, Cristina, Committee Chair
University of Central Florida, Degree Grantor
Type of Resource: text
Date Issued: 2019
Publisher: University of Central Florida
Language(s): English
Abstract/Description: Schwannomatosis (SWN) is a genetic disorder that predisposes affected individuals to develop multiple Schwannomas anywhere in the peripheral nervous system. This can be due to a mutation in the LZTR1 or SMARCB1 genes on chromosome 22. SWN has the defining clinical symptom of chronic pain and a lack of vestibular schwannomas, which sets it apart from other, related disorders such as Neurofibromatosis Type II (NF2). Currently, it is unknown what causes the chronic pain of SWN patients but it is hypothesized that cytokines may have promote the neuropathic pain experienced by patients. This study investigates the presence of the chemokine CCL2 and the cytokine IL6 in human SWN schwannomas and non-SWN schwannomas to determine if there is a difference in the presence of these cytokines between the two tumor types. It was demonstrated that all of the SWN schwannomas expressed both CCL2 and IL6 whereas the non-SWN schwannomas expressed only one or the other protein if either. These results indicate that the presence of these cytokines within the SWN schwannomas is different from non-SWN schwannomas and could be a potential contributing factor in the occurrence of neuropathic pain experienced by SWN which is part of the differential diagnosis for NF2 and SWN.
Identifier: CFH2000525 (IID), ucf:45627 (fedora)
Note(s): 2019-05-01
B.S.
College of Medicine, Biomedical Sciences
Bachelors
This record was generated from author submitted information.
Subject(s): Schwannomatosis
Pain
Cytokines
Immunohistochemistry
Neurofibromatosis Type 2
NF2
SWN
IL6
CCL2
Persistent Link to This Record: http://purl.flvc.org/ucf/fd/CFH2000525
Restrictions on Access: campus 2024-05-01
Host Institution: UCF

In Collections